Amedisys Price to Book Ratio 2010-2023 | AMED

Historical price to book ratio values for Amedisys (AMED) over the last 10 years. The current price to book ratio for Amedisys as of April 26, 2024 is 2.62.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Amedisys Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-04-26 91.79 2.68
2023-12-31 95.06 $34.28 2.77
2023-09-30 93.40 $33.51 2.79
2023-06-30 91.44 $32.53 2.81
2023-03-31 73.55 $34.83 2.11
2022-12-31 83.54 $34.04 2.45
2022-09-30 96.79 $32.93 2.94
2022-06-30 105.12 $32.04 3.28
2022-03-31 172.29 $31.34 5.50
2021-12-31 161.88 $30.03 5.39
2021-09-30 149.10 $29.11 5.12
2021-06-30 244.93 $26.89 9.11
2021-03-31 264.79 $24.24 10.92
2020-12-31 293.33 $24.71 11.87
2020-09-30 236.43 $23.10 10.24
2020-06-30 198.54 $22.26 8.92
2020-03-31 183.54 $21.01 8.74
2019-12-31 166.92 $19.87 8.40
2019-09-30 131.01 $18.71 7.00
2019-06-30 121.41 $17.52 6.93
2019-03-31 123.26 $16.27 7.58
2018-12-31 117.11 $15.09 7.76
2018-09-30 124.96 $13.98 8.94
2018-03-31 60.34 $16.14 3.74
2017-12-31 52.71 $15.20 3.47
2017-09-30 55.96 $15.13 3.70
2017-06-30 62.81 $14.57 4.31
2017-03-31 51.09 $14.33 3.56
2016-12-31 42.63 $13.73 3.11
2018-06-30 85.46 $12.86 6.64
2016-09-30 47.44 $13.30 3.57
2016-06-30 50.48 $12.77 3.95
2016-03-31 48.34 $12.32 3.92
2015-12-31 39.32 $12.21 3.22
2015-09-30 37.97 $11.70 3.25
2015-06-30 39.73 $11.29 3.52
2015-03-31 26.78 $10.92 2.45
2014-12-31 29.35 $11.84 2.48
2014-09-30 20.17 $11.49 1.76
2014-06-30 16.74 $11.18 1.50
2014-03-31 14.89 $11.13 1.34
2013-12-31 14.63 $11.45 1.28
2013-09-30 17.21 $11.66 1.48
2013-06-30 11.60 $14.48 0.80
2013-03-31 11.12 $14.71 0.76
2012-12-31 11.31 $14.61 0.77
2012-09-30 13.82 $18.08 0.76
2012-06-30 12.45 $17.28 0.72
2012-03-31 14.46 $17.25 0.84
2011-12-31 10.91 $17.55 0.62
2011-09-30 14.82 $17.05 0.87
2011-06-30 26.63 $31.11 0.86
2010-12-31 33.50 $30.09 1.11
2010-09-30 23.80 $29.95 0.79
2010-06-30 43.98 $28.78 1.53
2010-03-31 55.22 $27.59 2.00
2009-12-31 48.60 $26.12 1.86
2011-03-31 35.00 $30.71 1.14
2009-09-30 43.63 $24.57 1.78
2009-06-30 33.02 $23.19 1.42
2009-03-31 27.49 $21.91 1.25
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.999B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.25
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
U.S Physical Therapy (USPH) United States $1.516B 39.30
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00